Autopsy report · NCT05920408

Study to Assess EXS21546 in Combination in Patients With Advanced Solid Tumours

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Emerging data demonstrates challenge for EXS21546 to reach suitable therapeutic index.”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 month after it had already started.
Ran for about 6 months before it stopped.
6 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1, Phase 2
Sponsor: Exscientia AI Limited
Sponsor type: Industry
Conditions: Advanced Solid Tumours
Interventions: EXS21546
Participants: 6
Sites: 5
Countries: Belgium, France

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.